Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study. - Borriello G; Chisari CG; Maimone D; Mirabella M; Paolicelli D; Assogna F; Caradonna S; Patti F (Frontiers in neurology, 2024)